These data indicate that the topical treatment of 1% HA + CBD-SA-IL-4 improves wound closure when compared to the non-treated control, demonstrating that by modulating the signals present in the immune microenvironment of the wound, the dysregulation caused by the diabetic disease state can be modulated and therapeutic outcomes can be improved. The gene discussed is IL4; the disease is diabetes mellitus.